Nicotinic acetylcholine receptors (nAChRs) play diverse roles in C. elegans behavior and nervous system function. For example, levamisole, an agonist of a subset of nAChRs, activates receptors in the body muscle to induce contraction and spastic paralysis, and activates receptors in the egg-laying system to stimulate egg-laying. The responsiveness of nAChRs in body muscle has been shown previously to be modulated by experience--long term exposure to levamisole or other agonists leads to adaptation or desensitization of the initial response. We have recently found evidence for adaptation of nicotinic receptor activity in the egg-laying system as well.
ace-2;
ace-1 double mutants, which have elevated synaptic ACh due to defects in acetylcholine degradative enzymes, are egg-laying defective. Egg-laying in these animals can be stimulated by serotonin but not levamisole, indicating that chronic elevation of acetylcholine leads to desensitization of the levamisole receptor involved in egg-laying. Conversely weak hypomorphic alleles of
cha-1, which cause a reduction in acetylcholine levels, are levamisole hypersensitive, and lay eggs in a pattern (more rapid egg-laying within temporal clusters, see Waggoner and Schafer abstract) indicative of increased acetylcholine sensitivity. A similar pattern is seen in wild-type animals in which some but not all of the cholinergic neurons with inputs to the egg-laying muscles have been ablated. Pharmacological experiments also suggest the existence of a signaling pathway that regulates the sensitivity of nAChRs in the egg-laying muscles and/or neurons in response to long-term levels of acetylcholine. To identify components of nAChR adaptive pathways, we have performed genetic screens for mutants that fail to adapt to spastic paralysis and hypercontraction of body muscle by levamisole. At least one of the mutants we have identified so far,
lj10, also appears to affect ACh adaptation in the egg-laying circuit as well. Analysis of other mutants from our screen will be presented.